MarketInOut Stock Screener Log In | Sign Up

Dishman Carbogen Amcis Ltd

BSE • Healthcare • Biotechnology • Quote as of 10/27/2026 15:50
Dishman Carbogen Amcis Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeBSE
Market Capitalization21,393 mln
Float51.59 mln
Earnings Date11/05/2026

EPS

1.03
Stretched

P / E

143
Highly speculative

Piotroski F-Score

8 / 9
Very strong

Beneish M-Score

-2.76
Likely reliable

Relative Strength

67 / 100
Outperforming

Debt / Equity

0.46
Low leverage

Business Description

Dishman Carbogen Amcis Limited is an India-based company founded in 1983 that develops and manufactures specialized chemical and pharmaceutical products for healthcare companies around the world. Its work spans a broad range of offerings, from active drug ingredients and sterile injectables to vitamin compounds, sanitizers, and softgel formulations. Operating as part of the Adimans Technologies group and headquartered in Ahmedabad, the company serves both research-driven and commercial needs across the global pharmaceutical supply chain.

Key Fundamentals

EPS1.03
P/E143
ROE1.08
RPS185
ROIC1.54
ROA0.61
Interest Cover1.21
EBITDA, mln4,626
EV / EBITDA9.89
EV / EBIT23.33
Revenue, mln22,916
EV / Revenue2.00

Quote Details

Last 147.30
Change 8.55 (6.16%)
Open 139.95
Volume 14,192
Turnover 2,090,482
Average Volume 10,514

Financial Ratios

Pre-Tax Profit Margin3
Current Ratio1.23
Price / Book0.37
Price / Tangible Book1.66
Price / Free Cash Flow31.53
Debt / Equity0.46
Price / Sales1.07
PEG Ratio2.49

Financial Strength

Altman Z-Score0.61
Piotroski F-Score 8 / 9
Beneish M-Score-2.76
Price to Intrinsic Value0.49
Price to Lynch Fair Value3.47
Price to Graham Number1.37
Shiller PE Ratio39.09

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.99% 82 / 100   
1 Month -12.99% 25 / 100   
2 Months -23.02% 15 / 100   
6 Months -12.48% 40 / 100   
1 Year -48.58% 11 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog